Phase 2 Pharyngeal Cancer Clinical Trials
14 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–14 of 14 trials
Recruiting
Phase 2
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Oropharyngeal CancerThroat CancerHuman Papilloma Virus+2 more
Memorial Sloan Kettering Cancer Center121 enrolled7 locationsNCT05491512
Recruiting
Phase 2
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Head and Neck CancerLaryngeal CancerOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins75 enrolled1 locationNCT07209189
Recruiting
Phase 2
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
Oropharyngeal Cancer
University of Chicago30 enrolled1 locationNCT07290621
Recruiting
Phase 2
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
Oropharyngeal CancerSquamous Cell Carcinoma of the Oropharynx
University of Michigan Rogel Cancer Center150 enrolled1 locationNCT05894083
Recruiting
Phase 2
BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
Oropharyngeal CancerHPV
M.D. Anderson Cancer Center20 enrolled1 locationNCT05363709
Recruiting
Phase 2Phase 3
Trop2-targeted immunoPET Imaging of Solid Tumors
Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Phase 2
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
CarcinomaOropharyngeal Cancer
Zachary Zumsteg50 enrolled4 locationsNCT06445114
Recruiting
Phase 2
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
Nasopharyngeal Cancer
National University Hospital, Singapore50 enrolled1 locationNCT05305131
Recruiting
Phase 2
Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment
Nasopharyngeal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology32 enrolled4 locationsNCT04875611
Recruiting
Phase 2
Adebrelimab and Chemoradiotherapy in High-risk LANPC
Nasopharyngeal CancerNasopharyngeal Carcinoma
Sun Yat-sen University50 enrolled4 locationsNCT06349889
Recruiting
Phase 2
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Nasopharyngeal CancerNasopharyngeal CarcinomaNasopharynx Cancer+1 more
German Society for Pediatric Oncology and Hematology GPOH gGmbH57 enrolled31 locationsNCT06019130
Recruiting
Phase 2
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
Hypopharyngeal CancerLarynx Cancer
Fudan University82 enrolled1 locationNCT06039631
Recruiting
Phase 2
Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT
Nasopharyngeal Cancer
Fudan University198 enrolled1 locationNCT05628922
Recruiting
Phase 2
Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancer
Locally advanced nasopharyngeal cancer
Peter MacCallum Cancer Centre30 enrolled1 locationACTRN12605000509662